141 results
8-K
EX-99.1
SCLX
Scilex Holding Company
24 May 24
Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company
9:30am
” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products … -generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain
424B3
SCLX
Scilex Holding Company
13 May 24
Prospectus supplement
4:18pm
wholly owned subsidiaries, the “Company”) is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid …
We are an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid management products for the treatment
424B3
SCLX
Scilex Holding Company
13 May 24
Prospectus supplement
4:15pm
wholly owned subsidiaries, the “Company”) is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid …
We are an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid management products for the treatment
8-K
EX-99.1
SCLX
Scilex Holding Company
13 May 24
Regulation FD Disclosure
9:00am
” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products … revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic
424B3
1l5hr8ywe0
25 Apr 24
Prospectus supplement
4:35pm
424B3
7ba dmxsj3dqnk6
25 Apr 24
Prospectus supplement
4:33pm
8-K
EX-99.2
f6jgrauqyo7zy94lbqy
25 Apr 24
Scilex Holding Company Announces $15 Million Registered Direct Offering
4:30pm
8-K
EX-99.1
jpzc0v ro
25 Apr 24
Scilex Holding Company Announces $15 Million Registered Direct Offering
4:30pm
424B5
cjq0b5v4 r07n43
25 Apr 24
Prospectus supplement for primary offering
6:27am
8-K
EX-99.1
r49q0c1
16 Apr 24
Results of Operations and Financial Condition
4:06pm
424B3
xy19 a8ndmb
2 Apr 24
Prospectus supplement
5:20pm
424B3
6iye8y3t70
2 Apr 24
Prospectus supplement
5:19pm
POS AM
zlqn39j2g wzxbt
27 Mar 24
Prospectus update (post-effective amendment)
5:30pm
POS AM
c4uq3w iznoguman
27 Mar 24
Prospectus update (post-effective amendment)
5:29pm
424B3
fr2n5pm90ago
27 Mar 24
Prospectus supplement
4:18pm
424B3
stajw84ptan33d8uztu6
27 Mar 24
Prospectus supplement
4:13pm
8-K
EX-99.1
ys80 o9amz
27 Mar 24
Other Events
1:37pm
424B3
hlii6xvt
22 Mar 24
Prospectus supplement
5:18pm
424B3
q3elibyzx wh36huo8q
22 Mar 24
Prospectus supplement
5:16pm